Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.2100
-0.0100 (-4.55%)
May 15, 2026, 12:04 PM EST

Integrated BioPharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
5.833.621.681.320.330.21
Short-Term Investments
----0.010.07
Cash & Short-Term Investments
5.833.621.681.320.340.28
Cash Growth
96.76%115.56%27.43%283.67%23.83%-48.32%
Receivables
3.665.434.674.514.895.78
Inventory
8.129.3611.2410.2611.0611.7
Other Current Assets
0.370.360.290.280.340.25
Total Current Assets
17.9718.7617.8816.3716.6318
Property, Plant & Equipment
5.052.753.684.283.784.11
Long-Term Deferred Tax Assets
3.593.344.64.734.83.27
Other Long-Term Assets
0.050.050.060.060.050.07
Total Assets
26.6724.926.2125.4325.2525.44
Accounts Payable
2.972.272.512.273.213.5
Accrued Expenses
1.381.32.661.631.411.61
Short-Term Debt
----0.12.17
Current Portion of Long-Term Debt
----0.031.46
Current Portion of Leases
1.190.680.950.930.510.5
Total Current Liabilities
5.534.256.124.835.269.24
Long-Term Debt
----0.05-
Long-Term Leases
2.160.340.851.741.361.87
Total Liabilities
7.694.586.976.576.6811.11
Common Stock
0.060.060.060.060.060.06
Additional Paid-In Capital
51.9151.7751.551.2450.9250.52
Retained Earnings
-32.9-31.42-32.23-32.34-32.31-36.14
Treasury Stock
-0.1-0.1-0.1-0.1-0.1-0.1
Shareholders' Equity
18.9820.3219.2418.8618.5814.33
Total Liabilities & Equity
26.6724.926.2125.4325.2525.44
Total Debt
3.351.021.82.672.066
Net Cash (Debt)
2.482.6-0.12-1.36-1.71-5.72
Net Cash Per Share
0.080.08-0.00-0.05-0.05-0.18
Filing Date Shares Outstanding
31.0631.0630.129.9529.9529.82
Total Common Shares Outstanding
31.0631.0630.129.9529.9529.8
Working Capital
12.4514.5211.7511.5411.368.76
Book Value Per Share
0.610.650.640.630.620.48
Tangible Book Value
18.9820.3219.2418.8618.5814.33
Tangible Book Value Per Share
0.610.650.640.630.620.48
Land
-1.251.251.251.251.25
Machinery
-7.257.116.86.736.42
Leasehold Improvements
-1.411.341.371.371.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.